- Home
- WDFC vs CPRX Comparison
WDFC vs CPRX Comparison
Compare WDFC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDFC
- CPRX
- Stock Information
- Founded
- WDFC 1953
- CPRX 2002
- Country
- WDFC United States
- CPRX United States
- Employees
- WDFC N/A
- CPRX N/A
- Industry
- WDFC Major Chemicals
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- WDFC Industrials
- CPRX Health Care
- Exchange
- WDFC Nasdaq
- CPRX Nasdaq
- Market Cap
- WDFC 3.0B
- CPRX 2.6B
- IPO Year
- WDFC N/A
- CPRX 2006
- Fundamental
- Price
- WDFC $191.59
- CPRX $21.01
- Analyst Decision
- WDFC Strong Buy
- CPRX Strong Buy
- Analyst Count
- WDFC 3
- CPRX 5
- Target Price
- WDFC $300.67
- CPRX $33.20
- AVG Volume (30 Days)
- WDFC 157.7K
- CPRX 1.6M
- Earning Date
- WDFC 10-22-2025
- CPRX 11-05-2025
- Dividend Yield
- WDFC 1.95%
- CPRX N/A
- EPS Growth
- WDFC 24.95
- CPRX 183.96
- EPS
- WDFC 6.36
- CPRX 1.65
- Revenue
- WDFC $612,505,000.00
- CPRX $558,499,000.00
- Revenue This Year
- WDFC $6.13
- CPRX $16.51
- Revenue Next Year
- WDFC $5.76
- CPRX $9.58
- P/E Ratio
- WDFC $30.25
- CPRX $12.38
- Revenue Growth
- WDFC 6.52
- CPRX 28.55
- 52 Week Low
- WDFC $190.67
- CPRX $19.05
- 52 Week High
- WDFC $292.36
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- WDFC 29.91
- CPRX 58.65
- Support Level
- WDFC $190.67
- CPRX $20.34
- Resistance Level
- WDFC $194.99
- CPRX $21.22
- Average True Range (ATR)
- WDFC 3.94
- CPRX 0.62
- MACD
- WDFC -0.53
- CPRX 0.14
- Stochastic Oscillator
- WDFC 5.13
- CPRX 66.67
About WDFC WD-40 Company
WD-40 Co manufactures and sells lubricants and cleaning products. The firm's product categories include maintenance and cleaning products. Maintenance products include the WD-40 signature brand aerosol spray lubricant as well as degreasers, rust removers, and bicycle maintenance products. Cleaning products include toilet cleaners, carpet stain removers and deodorizers, and heavy-duty hand soaps used to clean grease. The company organizes itself into three segments based on geography: Americas, Europe/Middle East/Africa, and Asia-Pacific. The majority of the company's revenue comes from the Americas segment, which includes the United States, Canada, and Latin America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).